FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Federal health officials prepare new FDA and HHS actions in 2024 amid debates on mifepristone, vaccines, and psychedelic medicine policies.
Read MoreTenerife monitors public health after hantavirus outbreak on MV Hondius, with WHO issuing follow-up guidance amid three confirmed deaths.
Read MoreA 2026 retrospective study linked GLP-1 receptor agonists to reduced breast cancer mortality and recurrence in over 800,000 U.S. women, amid data quality concerns.
Read MoreA hantavirus outbreak linked to the MV Hondius cruise ship killed three, including a Dutch couple, prompting global health containment efforts.
Read MoreResearchers discovered that the HORMAD1 gene suppresses immune response in triple-negative breast cancer by promoting PD-L1 overexpression.
Read MoreEighteen Americans quarantined for 42 days in Omaha and Atlanta after Andes hantavirus outbreak on Dutch cruise ship MV Hondius caused three deaths.
Read MoreLuis Rodríguez retired as chief of the CDC’s Vessel Sanitation Program amid a hantavirus outbreak and recent staff cuts, the agency announced.
Read MoreA study of 440 women links accelerated monocyte aging to non-somatic depression symptoms, suggesting a potential early biomarker for mood-related depression.
Read MoreA 2024 AMA report shows nearly one in three U.S. physicians face malpractice lawsuits, raising medical liability insurance premiums nationwide.
Read MoreThe FDA will reconsider Atara Biotherapeutics’ rare cancer drug Ebvallo after initially rejecting it due to manufacturing concerns.
Read More